DOI: 10.1128/JVI.01474-18
Article Information
PubMed
Published By
History
- Received August 24, 2018
- Accepted September 30, 2018
- Published online December 10, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Lawrence Banks, Editor, International Centre for Genetic Engineering and Biotechnology
Article Versions
- Accepted Manuscript version (October 17, 2018).
- You are viewing the most recent version of this article.
Author Information
- Davor Nestića,
- Taco G. Uilb,
- Jiangtao Mac,
- Soumitra Royb,
- Jort Vellingab,
- Andrew H. Bakerd,
- Jerome Custersb and
- Dragomira Majhena,b
- aLaboratory for Cell Biology and Signalling, Division of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia
- bViral Vaccine Discovery and Early Development, Janssen Vaccines and Prevention BV, Leiden, The Netherlands
- cGlasgow Cardiovascular Research Centre College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
- dCentre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom
- Address correspondence to Jerome Custers, JCuster1{at}its.jnj.com, or Dragomira Majhen, dmajhen{at}irb.hr.
Citation Nestić D, Uil TG, Ma J, Roy S, Vellinga J, Baker AH, Custers J, Majhen D. 2019. αvβ3 integrin is required for efficient infection of epithelial cells with human adenovirus type 26. J Virol 93:e01474-18. https://doi.org/10.1128/JVI.01474-18.
